MOST SHARED
- Ritz-Carlton ?Struggling? in the US: President
- Garlic Price Rises Surpass Gold, Stocks in China
- New-Home Sales Jump 6.2% To Highest Level in Over Year
- S&P Stocks Trading at New 52-Week Highs
- Oil Price to Average $75.40 in 2010: Poll
- Half of Banks' Losses May Still Be Hidden: IMF Head
- The Executive Job Search
- Consumer Mood Improves, But Anxiety Over Personal Finances
- Jobless Claims Below 500,000, Durable Orders Slip
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
- 'Cancer of Fraud' Permeates Health Care System: Critics
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Judge Erases Couple's $525,000 Mortgage Payment
- For Many in US, It Will Be a Scaled-Down Holiday Season
- Where Do Pardoned Turkeys Go?
- Foreign Demand Boosts US 7-Year Treasury Sale
- Jobless Claims Below 500,000, Durable Orders Slip
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
- Garlic Price Rises Surpass Gold, Stocks in China
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
- S&P Stocks Trading at New 52-Week Highs
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
Text Size 
SAN FRANCISCO, Nov 02, 2009 /PRNewswire via COMTEX/ -- Soar BioDynamics, a San Francisco-based, personal health analytics company, announced today the availability of its updated, user-friendly Cancer Probability Report. The report is designed to give men and their doctors a brief but clear understanding of their likelihood of progressing prostate cancer and recommended action steps. In addition, the company's newly enhanced Web site, www.SoarBioDynamics.com, has expanded information about the PSA debate plus new navigational tools and graphic illustrations.
Through its 'Dynamic Screening' process, Soar's proprietary analytics technology helps men with elevated PSA scores and their doctors by providing users with simple access to a rigorous analysis of a patient's test results and medical history. This medical data is compared against tens of thousands of cases that can help the patient and doctor quickly narrow in on a personalized approach to care.
"Soar BioDynamics brings game-changing evidence-based analysis to help men and their doctors cut through the controversy and information overload," said CEO and Chief Scientist Tom Neville, Ph.D. "The Cancer Probability Report is easy to understand and helps bring context to PSA scores, allowing doctors to apply best practices that lead to better outcomes." Other enhanced resources on the Web site include: -- Elevated PSA? Provides patients concerned about abnormal PSA scores with a clear guide to the issues surrounding prostate screening tests. On the page, visitors can walk through what an elevated PSA score means, the problem of overtreatment and how to use Soar BioDynamics Screening with doctors.
-- Why Screen? Gives information about the prevalence of prostate cancer and an overview of the controversies surrounding screening tests.
-- About Soar BioDynamics: Discusses Soar's Dynamic Screening that synthesizes best practices validated by the latest peer-reviewed medical research for more reliable detection.
-- Dynamic Screening: Offers additional resources such as a glossary of medical terms, frequently asked questions and a page for physicians, with data points, research and links to leading medical centers using dynamic screening best practices.
How the Dynamic Screening Process Works Patients enter their medical information on www.SoarBioDynamics.com and receive via email their Cancer Probability Report, a personalized analysis with a cancer probability scenario and recommended action paths. Soar Dynamic Screening uses research-based mathematical analysis to augment existing information by trending patients' individual blood test results and other factors over time and comparing them to those of representative populations. As a result, Soar Dynamic Screening aids in the identification of early indications of prostatitis, BPH and cancer. This analysis may be used to reduce the risk of false positive biopsy results, recurrence of cancer after initial treatment and discovery of indolent cancer when compared to conventional screening. Users can now select to receive their Cancer Probability Report as a short easy-to-read summary or a more detailed analysis.
About Soar BioDynamics, Ltd.
Soar BioDynamics harnesses the power of advanced mathematical computation to bring bold new perspective to common medical test results with an easy-to-use Web-based system. Dynamic Screening for prostate cancer is Soar's first invention that has been expanded to screening for prostatitis and BPH. Soar's Cancer Probability Report can help bring context to PSA test results and help patients and doctors make more enlightened choices about further tests, referrals or treatments.
For more information regarding Soar BioDynamics, Ltd. or to view a sample report, please visit http://www.SoarBioDynamics.com.
SOURCE Soar BioDynamics, Ltd.
URL: http://www.SoarBioDynamics.com www.prnewswire.com Copyright (C) 2009 PR Newswire. All rights reserved -0- KEYWORD: California INDUSTRY KEYWORD: HEA
WEB SUBJECT CODE: SVY
PDT
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes